Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ADPT

Adaptive Biotechnologies Corp

Dec 10 • 04:00PM ET

6.71

Dollar change +0.27
Percentage change 4.19	%

Healthcare • Biotechnology • USA • NASD

Peers: ILMN TXG GH PACB QGEN TWST FATE BEAM CRSP VRTX

| Held by: ARKG IWM VTI VB VXF IWN IBB VBK SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.34	Insider Own	3.29%	Shs Outstand	147.56M	Perf Week	6.51%
Market Cap	990.26M	Forward P/E	-	EPS next Y	-0.93	Insider Trans	-0.54%	Shs Float	142.73M	Perf Month	15.29%
Income	-195.24M	PEG	-	EPS next Q	-0.26	Inst Own	92.21%	Short Float	5.75%	Perf Quarter	52.85%
Sales	177.28M	P/S	5.59	EPS this Y	28.53%	Inst Trans	1.74%	Short Ratio	6.92	Perf Half Y	94.49%
Book/sh	1.52	P/B	4.42	EPS next Y	16.26%	ROA	-30.60%	Short Interest	8.20M	Perf Year	42.46%
Cash/sh	1.65	P/C	4.07	EPS next 5Y	-	ROE	-66.69%	52W Range	2.28 - 6.70	Perf YTD	36.94%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-32.91%	ROI	-44.55%	52W High	0.15%	Beta	1.48
Dividend TTM	-	Quick Ratio	3.38	Sales past 5Y	27.46%	Gross Margin	50.91%	52W Low	194.30%	ATR (14)	0.46
Dividend Ex-Date	-	Current Ratio	3.52	EPS Y/Y TTM	1.86%	Oper. Margin	-93.79%	RSI (14)	66.36	Volatility	7.28% 8.71%
Employees	709	Debt/Eq	1.00	Sales Y/Y TTM	-1.34%	Profit Margin	-110.13%	Recom	1.50	Target Price	7.42
Option/Short	Yes / Yes	LT Debt/Eq	0.96	EPS Q/Q	37.46%	Payout	-	Rel Volume	1.21	Prev Close	6.44
Sales Surprise	15.41%	EPS Surprise	23.48%	Sales Q/Q	22.46%	Earnings	Nov 07 AMC	Avg Volume	1.18M	Price	6.71
SMA20	19.32%	SMA50	26.69%	SMA200	62.77%	Trades		Volume	1,439,672	Change	4.19%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-05-23	Resumed	JP Morgan	Overweight	$15
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$15
Dec-21-22	Upgrade	Piper Sandler	Neutral → Overweight	$7.50 → $14
Aug-25-22	Initiated	Credit Suisse	Underperform	$8
Jun-03-22	Initiated	Piper Sandler	Neutral	$7.50
Feb-16-22	Reiterated	JP Morgan	Overweight	$75 → $50
Feb-16-22	Reiterated	Goldman	Neutral	$54 → $21
Feb-16-22	Reiterated	BTIG Research	Buy	$35 → $30
Feb-16-22	Reiterated	BofA Securities	Buy	$40 → $32
Oct-15-21	Resumed	Cowen	Outperform
Mar-03-21	Downgrade	Goldman	Buy → Neutral	$74 → $63
Oct-08-20	Resumed	BTIG Research	Buy	$60
Sep-09-20	Initiated	Morgan Stanley	Equal-Weight	$42
Jun-03-20	Initiated	Goldman	Buy	$60
Jul-23-19	Initiated	BTIG Research	Buy	$46
Jul-22-19	Initiated	William Blair	Outperform
Jul-22-19	Initiated	Guggenheim	Buy	$47
Jul-22-19	Initiated	Goldman	Neutral	$32
Jul-22-19	Initiated	Cowen	Outperform
Jul-22-19	Initiated	BofA/Merrill	Buy	$45

Show Previous Ratings

Dec-09-24 09:53AM	Adaptive unveils data of MRD assessment test in blood cancer treatment (Medical Device Network)
Dec-07-24 06:30PM	Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ and Its Impact on Blood Cancer Treatment Decisions (GlobeNewswire)
Dec-05-24 07:16AM	Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area (Clinical Trials Arena)
Dec-03-24 07:30AM	Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting (GlobeNewswire)
Nov-29-24 09:40AM	Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year? (Zacks)
01:55PM	Loading…
Nov-25-24 01:55PM	Novotech report notes shift to adaptive designs in clinical trials (Clinical Trials Arena) +18.98%
Nov-15-24 09:55AM	Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know (Zacks) -8.96%
Nov-08-24 10:18AM	Q3 2024 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents)
02:29AM	Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ... (GuruFocus.com)
Nov-07-24 06:30PM	Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:15PM	Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:11PM	Adaptive Biotechnologies: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results (GlobeNewswire)
07:30AM	Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ for Assessing Measurable Residual Disease in Mantle Cell Lymphoma (GlobeNewswire)
Nov-06-24 07:28AM	Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result (GuruFocus.com)
04:05PM	Loading…
Oct-09-24 04:05PM	Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-04-24 04:35AM	Parametric company Adaptive Insurance launches operations (Life Insurance International) +9.09%
Aug-29-24 07:30AM	Adaptive Announces IVDR Certification for clonoSEQ in European Union (GlobeNewswire)
Aug-22-24 04:03PM	Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire) +10.45%
Aug-01-24 07:00PM	Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:20PM	Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:23PM	Adaptive Biotechnologies: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-21-24 06:00AM	3 Precision Medicine Stocks Tailoring Treatments (InvestorPlace)
Jul-15-24 12:00PM	Adaptive builds automation tools to speed up construction payments (TechCrunch)
Jul-11-24 04:05PM	Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024 (GlobeNewswire) +11.14%
May-31-24 07:30AM	Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress (GlobeNewswire)
May-29-24 04:05PM	Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
May-25-24 08:30AM	ARK Invest's Cathie Wood Snags These 3 Bargains Are They Right for Your Portfolio? (Benzinga)
May-24-24 09:58AM	Does Adaptive Biotechnologies Corporation (ADPT) Have Strong Growth Potential? (Insider Monkey)
06:00AM	Loading…
May-23-24 06:00AM	Mighty Mites: 3 Small-Cap Stocks Packing a Powerful Punch (InvestorPlace)
May-16-24 02:30PM	The Agency by AGI Denim Elevates Adaptive Denim (Sourcing Journal)
May-08-24 06:43PM	Why Adaptive Biotechnologies Topped the Market Today (Motley Fool) +11.95%
12:19PM	Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:54AM	Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-07-24 07:30PM	Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics (Zacks)
05:47PM	Adaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst Challenges (GuruFocus.com)
05:40PM	Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:37PM	Adaptive Biotechnologies: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-26-24 10:02AM	PhaseV and Quanticate partner to help sponsors run more adaptive trials (Clinical Trials Arena)
Apr-17-24 04:05PM	Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024 (GlobeNewswire) -11.27%
Apr-02-24 04:05PM	Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue (GlobeNewswire) -10.07%
Mar-27-24 04:30PM	The 7 Best Penny Stocks to Buy in Q2 2024 (InvestorPlace) +11.07%
08:30AM	Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024 (GlobeNewswire)
Mar-11-24 12:01AM	Team behind popular Falcon AI models unveils new startup with $20 million in funding aimed at helping companies tailor LLMs for business (Fortune)
Feb-22-24 04:05PM	Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference (GlobeNewswire)
Feb-15-24 10:09AM	Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:37AM	Q4 2023 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-14-24 05:16PM	Adaptive Biotechnologies Corp (ADPT) Faces Revenue Decline Amid Growth in MRD Segment (GuruFocus.com) +8.84%
04:43PM	Adaptive Biotechnologies: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-13-24 02:23AM	Here's Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4 (Insider Monkey) -7.65%
Feb-12-24 09:16AM	Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Jan-29-24 04:05PM	Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024 (GlobeNewswire)
Dec-27-23 04:05PM	Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-12-23 05:50AM	Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You? (Motley Fool)
Dec-11-23 03:30PM	16 Best Penny Stocks To Buy For 2024 (Insider Monkey)
Dec-09-23 08:30AM	Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ in Patients with Blood Cancers at the 65th ASH Annual Meeting (GlobeNewswire)
Dec-05-23 07:30AM	Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting (GlobeNewswire) -7.14%
Nov-10-23 01:52PM	Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2023 Earnings Call Transcript (Insider Monkey) -18.18%
Nov-09-23 04:17PM	Adaptive Biotechnologies: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-07-23 07:30AM	Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ Assay Across BeiGene's Lymphoid Malignancy Pipeline (GlobeNewswire)
Nov-02-23 04:05PM	Adaptive Biotechnologies to Report Third Quarter Financial Results on November 9, 2023 (GlobeNewswire) +9.46%
Oct-26-23 10:02AM	Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks)
Oct-17-23 07:57AM	Prothena (PRTA) Soars 18.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-27-23 05:14AM	Strength Seen in Adaptive Biotechnologies (ADPT): Can Its 9.5% Jump Turn into More Strength? (Zacks)
Sep-13-23 07:30AM	Adaptive Announces Launch of Epic Integration for clonoSEQ® (GlobeNewswire)
Aug-30-23 04:30PM	Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-28-23 11:53PM	3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List (InvestorPlace) +8.27%
Aug-24-23 10:29AM	Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks (Motley Fool) -6.62%
Aug-02-23 05:35PM	Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -12.44%
04:30PM	Adaptive Biotechnologies: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Adaptive Biotechnologies Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-29-23 12:12AM	Is it Still Worthy to Invest in Adaptive Biotechnologies (ADPT)? (Insider Monkey)
Jul-19-23 08:52AM	Viking Globals Performance, AUM, and Long-Term Stock Picks (Insider Monkey)
Jul-10-23 04:05PM	Adaptive Biotechnologies to Report Second Quarter Financial Results on August 2, 2023 (GlobeNewswire) +8.28% +6.12%
Jun-24-23 03:19PM	11 Best Medical Stocks Under $10 (Insider Monkey)
Jun-16-23 05:02PM	Why Shares of Adaptive Biotechnologies Jumped This Week (Motley Fool)
Jun-02-23 10:15AM	Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought (Motley Fool) +5.82%
07:34AM	Adaptive Biotechnologies Highlights New Data at ASCO 2023 and EHA 2023 Underscoring the clonoSEQ® Assays Impact as a Standard for Minimal Residual Disease Assessment in Patients with Hematologic Cancer (GlobeNewswire)
May-29-23 08:08AM	Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss (Simply Wall St.)
May-26-23 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
May-24-23 04:05PM	Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences (GlobeNewswire) +6.42%
May-23-23 09:54AM	Too Cheap to Ignore: Cathie Wood Snaps Up These 2 Stocks Under $10 (TipRanks)
May-15-23 07:50AM	3 Personalized Medicine Stocks to Buy for Long-Time Returns (InvestorPlace)
May-12-23 08:00AM	Adaptive Biotechnologies to Participate in the 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-09-23 07:30AM	Adaptive Biotechnologies Announces FDA Acceptance of Genentechs Investigational New Drug Application for the First Neoantigen-Directed T-Cell Therapy Product in Oncology (GlobeNewswire) +6.21%
May-04-23 09:13AM	Q1 2023 Adaptive Biotechnologies Corp Earnings Call (Thomson Reuters StreetEvents) -14.27%
May-03-23 05:25PM	Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.99%
04:05PM	Adaptive Biotechnologies Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 10:02AM	Analysts Estimate Blueprint Medicines (BPMC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Apr-26-23 10:02AM	Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-25-23 04:05PM	Adaptive Biotechnologies to Participate in the BofA Securities 2023 Healthcare Conference (GlobeNewswire) -9.82%
Apr-24-23 09:40AM	Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Apr-18-23 12:10PM	Investors Still Waiting For A Pull Back In Adaptive Biotechnologies Corporation (NASDAQ:ADPT) (Simply Wall St.)
Apr-12-23 07:30AM	Adaptive Biotechnologies Announces Translational Collaboration with Takeda to Measure Minimal Residual Disease with Its clonoSEQ® Assay Across Its Hematologic Malignancy Pipeline (GlobeNewswire)
Apr-06-23 04:05PM	Adaptive Biotechnologies to Report First Quarter Financial Results on May 3, 2023 (GlobeNewswire)
Mar-29-23 04:20PM	11 Most Promising Gene Editing Stocks According to Analysts (Insider Monkey)

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PISKEL KYLE	Chief Financial Officer	Nov 18 '24	Sale	4.98	248	1,235	154,330	Nov 19 06:45 PM
BOBULSKY SUSAN	Chief Commercial Officer, MRD	Oct 08 '24	Option Exercise	1.98	5,000	9,900	253,290	Oct 10 05:47 PM
Taylor Stacy L	SVP and General Counsel	Aug 22 '24	Sale	4.50	26,922	121,079	139,365	Aug 23 04:27 PM
STACY L TAYLOR	Officer	Aug 22 '24	Proposed Sale	4.50	26,922	121,079		Aug 22 04:18 PM
NEUPERT PETER M	Director	Mar 12 '24	Option Exercise	0.84	15,000	12,600	169,296	Mar 13 05:55 PM
PISKEL KYLE	Principal Accounting Officer	Mar 05 '24	Sale	3.43	7,727	26,504	123,318	Mar 06 07:43 PM
Taylor Stacy L	SVP and General Counsel	Mar 05 '24	Sale	3.43	13,381	45,963	166,287	Mar 06 07:42 PM
LO FRANCIS	Chief People Officer	Mar 05 '24	Sale	3.43	14,700	50,439	253,745	Mar 06 07:42 PM
BENZENO SHARON	Chief Commercial Ofc Imm Med	Mar 05 '24	Sale	3.44	29,390	100,994	327,415	Mar 06 07:42 PM
RUBINSTEIN JULIE	President	Mar 05 '24	Sale	3.47	39,070	135,764	472,754	Mar 06 07:41 PM
PETERSON TYCHO	Chief Financial Officer	Mar 05 '24	Sale	3.44	15,456	53,169	531,553	Mar 06 07:40 PM
ROBINS CHAD M	CEO and Chairman	Mar 05 '24	Sale	3.43	48,673	167,007	2,576,701	Mar 06 07:40 PM
BOBULSKY SUSAN	Chief Commercial Officer, MRD	Mar 05 '24	Sale	3.44	12,991	44,629	248,290	Mar 06 07:39 PM
NEUPERT PETER M	Director	Dec 13 '23	Option Exercise	0.84	100,000	84,000	122,968	Dec 15 04:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADPT

Adaptive Biotechnologies Corp

Upgrade your FINVIZ experience